- 1Department of Neurology, Hospital Universitario Burgos, Burgos, Spain
- 2Escuela Politécnica Superior, Universidad de Burgos, Burgos, Spain
- 3Department of Neurology, University of Pennsylvania, Philadelphia, PA, United States
- 4Parkinson and Movement Disorders Section, Institute of Neurology, Hospital de Clínicas, Montevideo, Uruguay
- 5Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, United States
- 6Department of Neurology, Centre of Expertise for Parkinson & Movement Disorders, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, Nijmegen, Netherlands
Background: The use of telemedicine has increased to address the ongoing healthcare needs of patients with movement disorders.
Objective: We aimed to describe the technical and basic security features of the most popular telemedicine videoconferencing software.
Methods: We conducted a systematic review of articles/websites about “Telemedicine,” “Cybersecurity,” and “Videoconferencing software.” Technical capabilities and basic security features were determined for each videoconferencing software.
Results: Twenty-six videoconferencing software programs were reviewed, 13 (50.0%) were specifically designed for general healthcare, and 6/26 (23.0%) were compliant with European and US regulations. Overall technical and security information were found in 5/26 software (19.2%), including Microsoft Teams, Google Hangout, Coviu, Doxy.me, and Thera platforms.
Conclusions: Detailed information about technical capabilities and data security of videoconferencing tools is not easily and openly retrievable. Our data serves as a guide for practitioners seeking to understand what features should be examined when choosing software and what options are available.
Background
Advances in technology have expanded telemedicine opportunities in medical practice, research, and education. After the declaration of the COVID-19 outbreak as a pandemic, the use of telemedicine has increased to address the ongoing healthcare needs of patients with chronic illnesses, for example, by the introduction of interdisciplinary telehealth services (1–3). Such services have helped reduce the number of in-person clinic visits and thereby minimize human exposures to Coronavirus. In response to the surging needs for remote care, many countries worldwide have expanded laws and regulations to permit greater adoption of telemedicine systems, have provided increased guidance on digital health technologies and cybersecurity expectations, and have expanded reimbursement options (4, 5). Many organizations, including the American Academy of Neurology and the International Parkinson and Movement Disorder Society, have also issued telemedicine guidelines (6, 7).
As demands increased, the pandemic caused a global surge in the use of videoconferencing tools (8). Movement disorders may be considered particularly fitting for distance health/remote visits with videoconferencing, because of the critical importance of observing phenomenology, visual aspects of the exam, speed, presence, distribution, and characteristics of tremor, dyskinesias, etc. In addition, patients with movement disorders are characterized by mobility limitations, and the sparse distribution of movement disorder specialists increasing the difficulty to access (1). Even before telehealth burst into the forefront, movement disorder specialists have been gathering videos of patients for decades at major meetings and weekly video conferences within their group. However, physicians need unbiased and expert guidance in choosing a video conferencing software, including insights into the legal framework, technical capabilities, licenses, patients' access, and costs. Compliance with software data protection requirements is likely to be different worldwide. Examples in data protection regulations include the European Union General Data Protection Regulation (GDPR), which is essential for protecting personal data in Europe. In North America, physicians would look for Health Insurance Portability and Accountability Act (HIPAA) compliant software. Given the increasing offers for videoconferencing in the market, in this article, we describe the technical and basic security standard features of the most popular telemedicine videoconferencing software platforms to inform neurologists interested in developing telemedicine programs. This review is not aimed to provide international or national-based legal information for videoconferencing tools.
Procedure
For the selection of recent videoconferencing software, we conducted a systematic review of articles published since January 2020 from Medical and Telemedicine Societies, PubMed, and Google using the following keywords: “Telemedicine,” “Cybersecurity,” and “Videoconferencing software.” Only articles and websites in English with detailed information about videoconferencing software characteristics were reviewed. We excluded supplementary applications designed to increase the security to access electronic health medical records or video-based pose estimation of movements with artificial intelligence-based analysis. The following characteristics were determined for each videoconferencing software: chat capability (ability to send/receive text messages), call capability (phone calls), videoconference capability (one-to-one, group meetings), screen share capability (ability to share your screen with different documents), healthcare-based (previous use in medicine), pricing, supported operative systems and platforms, communications protection (encryption), extra security layer, security measures in group meetings (administration of pass-invitations), Security Standard Compliance, and Privacy policy.
Results
Twenty-six videoconferencing software programs were identified (Tables 1, 2; Supplementary Figure 1). Regarding the technical capabilities, 13/26 (50.0%) were designed specifically for use in healthcare. All requested information was only found in 5/26 (19.2%) applications, including frequently asked information by users such as pricing in 11/26 (42%), and security information in 11/26 (43%) with 6 out 26 (23.0%) were both compliant with HIPAA and GDPR. All detailed information and definitions are included in Tables 1, 2.
Discussion
This article summarizes the main technical and security aspects of commercially available videoconferencing software for healthcare use, features that a clinician should consider while choosing a videoconferencing software. Overall, the main features of current videoconferencing software are applicable to healthcare in general and they are not specific to movement disorders. Surprisingly, we collected complete data regarding capability and security in less than 20% of videoconferencing software platforms in use, suggesting that information about technical capabilities and data security is not easily and openly accessible for interested future users. In addition, complete and explicit information on whether the vendor/subcontractors have access to the data, including the video and other medical information, was also not entirely available for review.
In this review, we have not included other essential aspects for a successful videoconference visit. Firstly, the size of the room and the number of participants where the videoconference is conducted. These aspects will determine the exact type of equipment (camera, microphone, speakers, etc.) we will need to get good video and audio quality. Secondly, it is recommended to use videoconference etiquette tips, including adequate lighting in a professional environment, eliminating background noise and looking straight at the camera, dressing professionally, and avoiding multitasking1 (9).
Given the significantly increased use of remote care delivery during the Covid-19 pandemic, neurologists are facing an opportune time to expand the access to patients with movement disorders using videoconferencing tools (3, 10). A shift to video conferencing visits must be accompanied by efforts to prepare for and protect against breaches of security and privacy. Concern over such breaches is one of the many barriers and challenges against the more widespread adoption of telemedicine (2). Cybersecurity must be appropriately addressed to continue providing the best and safest care to our patients. To date, the most common strategies to enhance the cybersecurity of videoconferences include (1) password requirements, preventing unsolicited visitors from joining the meeting; (2) careful selection of software with the involvement of the IT department; (3) downloading the official release with regular updates for security patches; (4) ensuring there is no storage of video or medical data by the vendor; (5) identifying and monitoring attendees, with an alert when new attendees join the videoconference; (6) setting up waiting rooms that allow the organizer to determine whether those waiting are eligible to participate; and (7) encrypting meeting recording, making the information unreadable when obtained by third parties.
Presently and in the future, telemedicine may continue to be necessary to overcome infectious or other public health disasters/pandemics, where a healthcare response can be mobilized in a short period of time (5). In response to Covid-19 pandemic, telephone calls, messaging apps, or video visits have replaced or supplemented outpatient clinics (5). New regulations for telemedicine were created, and for example, in South Korea, the illegal status was lifted to follow established patients through telemedicine (5). Governments from several countries have initiated legislation to promote and regulate telemedicine and/or amended their prior restrictive regulations, including the US2, Europe (11), and Saudi Arabia 3.
The strength of our conclusions is tempered by some limitations, including selection bias given the lack of information on non-English-based videoconference software. There are also important aspects to users which were not included in our table, such as “How” to conduct a videoconference (with a laptop, mobile phones, tablets) and with “Whom” (with patients, caregivers, or other health professionals), which are decisive critical factors for a successful videoconference in certain populations. We also did not elaborate on the ongoing debate concerning the best indications for the use of videconference visits in movement disorders. However, most would appear to agree that videoconferencing should be reserved for follow-up visits, intermingled with in-person visits to the hospital whenever possible, but preferably not for making a diagnosis in a new patient (12, 13). Previous literature has shown a digital gap and poor eHealth literacy (14), especially in elderly, uneducated patients, limiting telemedicine's usefulness in certain groups of patients. An extra layer of support is sometimes required to facilitate and expand the use of videoconferences by patients, including caregivers' assistance, telemedicine health personnel assistants (“telepresenters”), and the use of health care facilities designed to establish videoconferences. One of the most established telemedicine programs to date is “The Ontario Telemedicine Network” (OTN) in Canada, which employs strategies to ensure that even patients with limited technological capabilities can access telemedicine care. The OTN supports all practice specialties, including movement disorders and those with deep brain stimulation (DBS)4. Therefore, an optimal telemedicine program with videoconferencing should balance security aspects with user-friendliness for patients and providers, cost, browser integration, operating systems, mobile platforms, and electronic health record integrations.
In conclusion, we have described the main technical and security features of the most popular videoconferencing tools used at present. Our data serves as a checklist guide for practitioners to understand what features should be examined when choosing a videoconference software and available options. However, because technology is a science characterized by a fast evolution, it is necessary to keep updating this type of information to neurologists interested in developing telemedicine programs.
Author Contributions
All authors confirm that they have significantly contributed to the review of the literature, writing and review of this article.
Funding
This work was supported by the project PI19/00670 of the Ministerio de Ciencia, Innovación y Universidades, Instituto de Salud Carlos II, Spain.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fneur.2021.745917/full#supplementary-material
Footnotes
1. ^Available online at: https://www.vault.com/blogs/workplace-issues/best-practices-for-video-conference-etiquette.
2. ^Available online at: https://www.commonwealthfund.org/publications/issue-briefs/2021/jun/states-actions-expand-telemedicine-access-covid-19.
3. ^Available online at: https://nhic.gov.sa/en/Initiatives/Documents/TheGoverningRulesOfTelehealthEnglishEstablishingRules.pdf.
4. ^Available online at: https://otn.ca; Visited at May, 10th 2021.
References
1. Ben-Pazi H, Browne P, Chan P, Cubo E, Guttman M, Hassan A, et al. The promise of telemedicine for movement disorders: an interdisciplinary approach. Curr Neurol Neurosci Rep. (2018) 18:26. doi: 10.1007/s11910-018-0834-6
2. Shalash A, Spindler M, Cubo E. Global perspective on telemedicine for parkinson's disease. J Parkinsons Dis. (2021) 11:S11-8. doi: 10.3233/JPD-202411
3. Cubo E, Hassan A, Bloem BR, Mari Z, Group MD-TS. Implementation of telemedicine for urgent and ongoing healthcare for patients with parkinson's disease during the COVID-19 pandemic: new expectations for the future. J Parkinsons Dis. (2020) 10:911–3. doi: 10.3233/JPD-202108
4. Rockwell KL, Gilroy AS. Incorporating telemedicine as part of COVID-19 outbreak response systems. Am J Manag Care. (2020) 26:147–8. doi: 10.37765/ajmc.2020.42784
5. Hassan A, Mari Z, Gatto EM, Cardozo A, Youn J, Okubadej N, et al. Global Survey on telemedicine utilization for movement disorders during the COVID-19 pandemic. Mov Disord. (2020) 35:1701–11. doi: 10.1002/mds.28284
6. Telemedicine, in Your Movement Disorders Practice,. Available online at: https://www.movementdisorders.org/MDS/About/Committees–Other-Groups/Telemedicine-in-Your-Movement-Disorders-Practice-A-Step-by-Step-Guide.htm (accessed July 22, 2020).
7. Telemedicine and COVID-19 Implementation Guide. Available online at: https://www.aan.com/siteassets/home-page/tools-and-resources/practicing-neurologist–administrators/telemedicine-and-remote-care/20-telemedicine-and-covid19-v103.pdf. (accessed July 22, 2020).
8. John N, Wellmann M. Data security management and data protection for video conferencing software. Int Cybersecur Law Rev. (2020) 1:39–50. doi: 10.1365/s43439-020-00013-4
9. Telemedicine and COVID-19 Implementation Guide. Available online at: https://www.aan.com/siteassets/home-page/toolsand-resources/practicing-neurologist–administrators/telemedicine-and-remote-care/20-telemedicine-and-covid19-v103.pdf (accessed April 20, 2020).
10. Doraiswamy S, Abraham A, Mamtani R, Cheema S. Use of telehealth during the COVID-19 pandemic: scoping review. J Med Internet Res. (2020) 22:e24087. doi: 10.2196/24087
11. European Commission. DG CONNECT, Exchange of Electronic Health Records across the EU. Available online at: https://ec.europa.eu/digital-singlemarket/en/exchange-electronic-health-records-across-eu. (accessed April 20, 2020).
12. Dorsey ER, Bloem BR, Okun MS. A new day: the role of telemedicine in reshaping care for persons with movement disorders. Mov Disord. (2020) 35:1897–902. doi: 10.1002/mds.28296
13. Mulroy E, Menozzi E, Lees AJ, Lynch T, Lang AE, Bhatia KP. Reply to: a new day: the role of telemedicine in reshaping care for persons with movement disorders. Mov Disord. (2020) 35:1903–4. doi: 10.1002/mds.28315
Keywords: telemedicine, movement disorders, Parkinson's disease, videoconference, telehealth
Citation: Cubo E, Arnaiz-Rodriguez A, Arnaiz-González Á, Díez-Pastor JF, Spindler M, Cardozo A, Garcia-Bustillo A, Mari Z and Bloem BR (2021) Videoconferencing Software Options for Telemedicine: A Review for Movement Disorder Neurologists. Front. Neurol. 12:745917. doi: 10.3389/fneur.2021.745917
Received: 22 July 2021; Accepted: 14 September 2021;
Published: 11 October 2021.
Edited by:
Aasef G. Shaikh, Case Western Reserve University, United StatesReviewed by:
Abhimanyu Mahajan, Rush University Medical Center, United StatesRoopa Rajan, All India Institute of Medical Sciences, India
Copyright © 2021 Cubo, Arnaiz-Rodriguez, Arnaiz-González, Díez-Pastor, Spindler, Cardozo, Garcia-Bustillo, Mari and Bloem. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Esther Cubo, bWN1Ym8mI3gwMDA0MDtzYWx1ZGNhc3RpbGxheWxlb24uZXM=